Testing your patients for vitamin D1,2
Many physicians recognize the importance of testing vitamin D levels in their high-risk patients, such as older adults and those who are dark-skinned or receive little or no sun exposure. Patients with low vitamin D levels are at risk of osteoporosis and cardiovascular disease, as well as cancer and respiratory disease. Patients who are pregnant or lactating should be tested too, since they represent another high-risk group. Deficiency in pregnancy can lead to preeclampsia, and deficiency while lactating can cause rickets in infants.
An important part of the testing process is advising patients on their vitamin D supplementation needs based on their test results. Here’s what you need to know.
What do vitamin D tests measure?1,2
Vitamin D tests, which include immunoassays and liquid chromatography-mass spectrometry LC/MS/MS, measure the level of 25(OH)D, the main form of circulating vitamin D.
Optimal levels
Vitamin D levels of 30 to 100 ng/mL are considered optimal.
Low levels—suboptimal
Vitamin D levels between 20 and 29 ng/mL are considered suboptimal. Vitamin D insufficiency may lead to elevated parathyroid hormone (PTH) levels (secondary hyperparathyroidism).
Low levels—deficiency
Vitamin D levels <20 ng/mL are considered vitamin D deficient.
Vitamin D deficiency may lead to elevated parathyroid hormone (PTH) levels (secondary hyperparathyroidism).
If your patients' test results reveal that they are vitamin D deficient, the Endocrine Society recommends that they receive vitamin D supplementation. (See the chart below.)
Additional considerations
Monitor serum calcium levels in order to prevent hypercalcemia in patients with
extrarenal production of 1,25(OH)D and in those with primary hyperparathyroidism.
Recommendations for supplementation in vitamin D-deficient patients1
Supplementation in vitamin D-deficient patients depends on your patient's age and medical history. Use this table as a guide to help you advise your patients on recommendations for supplementation:
Recommendations for supplementation in Vitamin D-deficient patients
| Daily | Weekly | Maintenance* | |
Infants and toddlers |
2,000 IU |
50,000 IU |
400-1,000 IU/day |
Children |
2,000 IU |
50,000 IU |
600-1,000 IU/day |
Adults |
6,000 IU |
50,000 IU |
1,500-2,000 IU/day |
Obese Patients / Patients with malabsorbtion syndromes / Patiens taking certain medications |
6,000-10,000 IU |
N/A |
3,000-6,000 IU/day |
*After achieving 25(OH)D levels >30 ng/mL.
Specific supplementation guidelines are not available for pregnant and lactating women. Both groups should be advised to supplement if tests show low levels of vitamin D.
Take action
References
- Holick M, Binkley N, Bischoff-Ferrari H, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.
- Khan Q, Fabian C. How I treat vitamin D deficiency. JOP. 2010;6(2):97-101.
During the COVID-19 health crisis, fast action and trusted information matter more than ever.
Find out what's happening
Endocrine disorders
Endocrine disorders
Site map
•
Privacy
•
Terms
•
Cookie notice
•
Contact us
•
Language assistance / non-discrimination
•
Asistencia de idiomas / Aviso de no discriminación
•
語言協助 / 不歧視通知
•
Privacy Shield
•
DO NOT SELL MY PERSONAL INFORMATION
Quest, Quest Diagnostics, the associated logo, Nichols Institute, and all associated Quest Diagnostics marks are the registered trademarks of Quest Diagnostics. All third-party marks—®' and ™'—are the property of their respective owners. © 2000-2021 Quest Diagnostics Incorporated. All rights reserved.
Image content features models and is intended for illustrative purposes only.